Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-113381
Filing Date
2019-04-22
Accepted
2019-04-22 16:11:04
Documents
4
Period of Report
2019-05-30
Effectiveness Date
2019-04-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d707175ddef14a.htm DEF 14A 1148019
2 GRAPHIC g707175g52j05.jpg GRAPHIC 139919
3 GRAPHIC g707175g55b88.jpg GRAPHIC 130640
4 GRAPHIC g707175g74w49.jpg GRAPHIC 84658
  Complete submission text file 0001193125-19-113381.txt   1638483
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34207 | Film No.: 19759549
SIC: 2834 Pharmaceutical Preparations